Metasphere Labs Inc.
LABZ
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -102.17% | -99.89% | -99.93% | -90.27% | -48.07% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -102.17% | -99.89% | -99.93% | -90.27% | -48.07% |
| Cost of Revenue | -110.45% | -99.36% | -99.54% | -85.65% | -36.49% |
| Gross Profit | -100.15% | -99.99% | -99.99% | -91.11% | -50.27% |
| SG&A Expenses | -45.47% | -43.59% | -27.01% | -15.74% | -8.72% |
| Depreciation & Amortization | -- | -- | -- | -62.11% | -47.13% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -57.52% | -57.21% | -47.64% | -32.53% | -14.49% |
| Operating Income | -23.88% | -1,174.48% | -221.65% | -211.85% | -580.47% |
| Income Before Tax | 43.25% | -17.84% | -31,109.52% | -347.94% | 64.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.25% | -17.84% | -31,109.52% | -347.94% | 64.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.25% | -17.84% | -31,109.52% | -405.11% | 64.05% |
| EBIT | -23.88% | -1,174.48% | -221.65% | -211.85% | -580.47% |
| EBITDA | 3.75% | -536.58% | -206.16% | -193.94% | -333.57% |
| EPS Basic | 57.21% | -182.95% | -114.77% | 89.00% | 98.10% |
| Normalized Basic EPS | 20.06% | -284.00% | -113.06% | -160.91% | 93.46% |
| EPS Diluted | 47.87% | -23.96% | -119.05% | 88.34% | 98.05% |
| Normalized Diluted EPS | 23.50% | -420.75% | -114.05% | -182.05% | 93.41% |
| Average Basic Shares Outstanding | 13.06% | 33.53% | 79.03% | 143.85% | 554.19% |
| Average Diluted Shares Outstanding | 1.97% | 8.26% | 35.18% | 65.22% | 364.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |